Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT02387450
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT02387450
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT02387450. Randomized; triple masking; primary purpose treatment. Start 2015-09 (registry gives no type); primary completion 2017-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Reduced Cardiovascular Morbi-mortality by Sildenafil in Patients With Arterial Claudication
- Condition
- Peripheral Arterial Disease
- Intervention (Drug)
- Sildenafil
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital, Angers
Record details
- Record id
cardio:ct-nct02387450- Content hash
4b8dba18450ca3057062c0b869c5f2538e510ef009751c7522663d605970a885